Given AstraZeneca’s biological concerns, Australia will give priority to Pfizer’s covid-19 vaccine for people under 50.
Madrid, Spain (Europa Press)-due to AstraZeneca drugs and thrombosis.
After the European Medicines Agency (EMA) concluded that there was a “possible link” between the drug and low-level blood clots, a group of medical experts from the Australian government met on Wednesday to assess the use of the AstraZeneca vaccine. Therefore, he decided to include these events in the list of “very rare” side effects of the vaccine.
The Chief Medical Officer of the Australian Government Paul Kelly announced at a press conference: “For adults under 50 who have not received the first dose of vaccine, Pfizer vaccine is preferred over AstraZeneca.” ABC News.
In addition, he clarified that people who have received the first dose of AstraZeneca but have not experienced any “adverse side effects” can also get the second dose.
The United Kingdom concluded on Wednesday that because of the drug’s relationship with blood clots, alternative medicines should be provided to people under 30 years of age.